Form 4: Guardant Health Director Myrtle S. Potter Reports Stock Transactions
SEC Form 4 Filing
Director Myrtle S. Potter reports the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.
Summary
- On September 15, 2024, Myrtle S. Potter, a director of Guardant Health, Inc., reported a transaction involving restricted stock units.
- 68 restricted stock units vested and were converted into 68 shares of common stock.
- The price per share was $0.
- Following the transaction, Potter directly owns 13,516 shares of Guardant Health common stock and 890 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by a company director, with no inherent positive or negative implications for the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company directors.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it involves a small number of shares relative to the company's total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| October 15, 2022 | Initial vesting date for 25% of the restricted stock units. |
| September 15, 2024 | Date of transaction: vesting and conversion of restricted stock units. |
| September 16, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.